alendronate has been researched along with Leukocyte Disorders in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Leukocyte Disorders: Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.
Excerpt | Relevance | Reference |
---|---|---|
"Atorvastatin (ATV) has bone anabolic properties, and alendronate (ALD) is an important antiresorptive drug." | 1.40 | Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats. ( Alencar, NM; Benevides, NM; Goes, P; Lima, V; Melo, IM; Ribeiro, RA; Silva, LM, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goes, P | 1 |
Melo, IM | 1 |
Silva, LM | 1 |
Benevides, NM | 1 |
Alencar, NM | 1 |
Ribeiro, RA | 1 |
Lima, V | 1 |
1 other study available for alendronate and Leukocyte Disorders
Article | Year |
---|---|
Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats.
Topics: Acid Phosphatase; Alanine Transaminase; Alendronate; Alkaline Phosphatase; Alveolar Bone Loss; Anima | 2014 |